Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > RE:Stockhouse Bullboard Content Management Changes
View:
Post by Duster340 on Dec 01, 2022 1:51am

RE:Stockhouse Bullboard Content Management Changes

i guess free speach is not allowed, you guys better hope elon musk does not buy S.H. lol,  otherwise it will turn into a cesspool like twiter was. missinformation is ok though cause i read alot of that, it never gets taken down?
Comment by MrMugsy on Dec 01, 2022 8:55am
This site is designed for debate around potential misinformation Duster. Just stay focused on ATE. ------------------- Note:  Today is Dec 1. Indomethacin/Ketotifen P3 COVID trial is due to end today (give-or-take). Some clues may come out of this trial re. our indomethacin based Antiviral and the potential for lung inflammation. Further down the road, I'm assuming Antiviral/IBD ...more  
Comment by StockingUp21 on Dec 01, 2022 10:07am
How to avoid labelled as misinformation. Say IMO after
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities